US Device Guide
The Cardiac Interventions Today Europe Device Guide offers a searchable, comprehensive listing of the available interventional cardiology devices in the United States.
Featured Video
EXCELLENCE IN PRACTICE: A Game-Changing Solution with Dr. William Lombardi
Sponsored by BIOTRONIK
Current Supplement
News
Study From STS Database Supports Surgery Versus TAVR in Young Adults
January 27, 2020 -- The Society of Thoracic Surgeons (STS) announced study findings showing that open heart surgery remains the best option for young and middle-aged adults wi…
Study From CathPCI Registry Analyzes Trends in Usage and Outcomes of Coronary Atherectomy
January 24, 2020 -- Nirat Beohar, MD, et al conducted a study that sought to assess the trends in usage, interhospital variability, and outcomes with coronary atherectomy (CA)…
CE Mark Approval Extended for BioVentrix’s Revivent TC LIVE Therapy
January 22, 2020 -- BioVentrix, Inc. announced the extension of European CE Mark approval for its Revivent TC transcatheter ventricular enhancement system for heart failure to…
FDA Approves Medtronic's Micra AV to Treat Atrioventricular Block
January 21, 2020 -- Medtronic announced it has received FDA approval of Micra AV, the company’s small pacemaker with atrioventricular (AV) synchrony. Micra AV is indicat…
PREDICT-LAA Trial Enrolls First Patient to Study FEops HeartGuide Computer Simulation Device
January 17, 2020 -- FEops announced that the first patient has been enrolled in the physician-initiated PREDICT-LAA trial. Headquartered in Gent, Belgium, FEops is focused on …
Study Shows More Than Half of United States Clinical Trials Fail to Comply With Law on Reporting Results
January 17, 2020 -- The Lancet announced the publication of a study finding that only 41% of clinical trial results are reported promptly onto the United States trial registry…
BioCardia’s Morph DNA Deflectable Guide Catheter Cleared by FDA
January 14, 2020 -- BioCardia, Inc. announced FDA 510(k) clearance for the Morph DNA deflectable guide catheter used to guide the Helix biotherapeutic delivery system during C…
Enrollment Completed in SafePass 2 Study of Emboline’s Embolic Protection Catheter for TAVR
January 15, 2020 -- Emboline, Inc. announced the completion of enrollment in the company’s SafePass 2 clinical study of the Emboliner embolic protection catheter for use…
Three-Year Findings Published for Mortality of Repeat Revascularizations in the EXCEL Trial
January 15, 2020 -- The 3-year findings from an investigation to determine the incidence and impact on mortality of repeat revascularization after index percutaneous coronary …
